Table 3.
Univariate and multivariate analysis of OS in patients with oral cavity squamous cell carcinoma after treatment.
Variables | Univariate | Multivariate | ||||
---|---|---|---|---|---|---|
Hazards Ratio | 95% CI | P-value | Hazards Ratio | 95% CI | P-value | |
Age (Years) | ||||||
≤65 | Reference | Reference | ||||
>65 | 1.435 | 1.011–2.039 | 0.0434† | 1.528 | 1.063–2.197 | 0.0220† |
Sex | ||||||
Male | Reference | Reference | ||||
Female | 1.226 | 0.779–1.928 | 0.3781 | 1.158 | 0.725–1.850 | 0.5381 |
Overall Pathological Stage | ||||||
I | Reference | Reference | ||||
II | 2.345 | 1.110–4.954 | 0.0256† | 2.603 | 1.181–5.738 | 0.0177† |
III | 3.679 | 1.735–7.798 | 0.0007† | 3.391 | 1.504–7.644 | 0.0032† |
IV | 7.690 | 3.912–15.117 | <0.0001† | 4.928 | 2.213–10.974 | <0.0001† |
ENE | ||||||
(−) | Reference | Reference | ||||
(+) | 3.665 | 2.725–4.929 | <0.0001† | 2.096 | 1.477–2.975 | <0.0001† |
Perineural Invasion | ||||||
No | Reference | Reference | ||||
Yes | 1.926 | 1.453–2.553 | <0.0001† | 1.061 | 0.764–1.473 | 0.7222 |
Cell Differentiation* | ||||||
W-D + M-D | Reference | Reference | ||||
P-D | 1.916 | 1.305–2.814 | 0.0009† | 1.359 | 0.908–2.034 | 0.1363 |
Tumor Depth (mm) | ||||||
<10 mm | Reference | Reference | ||||
≥10 mm | 2.423 | 1.801–3.259 | <0.0001† | 1.119 | 0.773–1.619 | 0.5517 |
Surgical margin | ||||||
<5 mm | Reference | Reference | ||||
≥5 mm | 0.696 | 0.518–0.934 | 0.0158† | 0.914 | 0.675–1.238 | 0.5622 |
Albumin (gl−1) | ||||||
≥4.5 | Reference | |||||
<4.5 | 2.109 | 1.575–2.825 | <0.0001† | |||
NLR | ||||||
≤2.28 | Reference | |||||
>2.28 | 1.759 | 1.320–2.345 | 0.0001† | |||
ANS | ||||||
score = 0 | Reference | Reference | ||||
score = 1 | 1.802 | 1.201–2.703 | 0.0044† | 1.550 | 1.020–2.354 | 0.0400† |
score = 2 | 3.181 | 2.124–4.763 | <0.0001† | 1.962 | 1.283–3.001 | 0.0019† |
Abbreviations: OS = overall survival; CI = confidence interval; ENE = extranodal extension; NLR = neutrophil-t-lymphocyte ratio; ANS = albumin/NLR score.
*W-D = well-differentiated, M-D = moderately differentiated, and P-D = poorly differentiated, squamous cell carcinoma.
†Statistically significant.